MedTrace Logo

Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt

NCT04861012 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2021-04-27

No results posted yet for this study

Summary

Primary outcome Screen for MAFLD among patients attending to the Nutrition clinic in Al Rajhi hospital.

Secondary outcome

* Determining the degrees of fibrosis and steatosis in patients with MAFLD
* Determining the rate of obesity, diabetes mellitus (DM), hypertension (HTN), hyperlipidemia in patients with MAFLD.
* Determining the rate of patients with other associated chronic liver disease (CLD).

Conditions

  • Steatohepatitis, Nonalcoholic

Interventions

DEVICE

Ultrasound

All subjects initially will be subjected to abdominal ultrasound, and if fatty liver is detected fibroscan will be done

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Sherif Kamel, Professor · Assiut University

  • Mohammed Medhat, Lecturer · Assiut University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2022-09-30
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04861012 on ClinicalTrials.gov